Proactol™ has the backing of 4 pre-clinical and clinical studies.

Proactol™'s active ingredients were put to the test in a recent 'double blind placebo controlled cross over study'. Healthy participants took part and were randomly divided into two groups.

One group received Proactol™ active ingredient and the other group received a placebo for a one week period. After the one week period both the groups swapped with a washout period between the two test periods. Participants also followed a strict diet to ensure a standardized intake of fats.

The quantity of fat that was blocked from entering the body compared to the quantity ingested increased, on average, by 27.4% in the group of volunteers taking Proactol™'s active ingredient, compared to those taking the placebo.

In recent double-blind studies, Proactol™'s active ingredient were put to the test. The studies showed that the volunteers that were taking Proactol™'s active ingredients bound on average over 27% more dietary fat when compared to the group that were taking a placebo. Extensive research has shown that a reduction in dietary fat intake contributes to weight loss.

A sustained weight loss as modest of 5-10% has also been shown to improve disorders associated with being overweight, such as high blood pressure, high cholesterol, cardiovascular problems and diabetes. Some other benefits include increased joint flexibility, less aches and pains, and improved concentration and energy levels.